Back to 
NATIXIS
NATIXIS
CRVS
Showing 0 of 7 quarters
Position history for NATIXIS's holdings in CORVUS PHARMACEUTICALS INC
No. Natixis exited its CRVS (Corvus Pharmaceuticals) position in Q1 2024. Its Q4 2023 13F listed 800 shares worth $1,408. Natixis first reported CRVS in Q1 2021 and held it in 5 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.